Current Edition

Phase III Clinical Trials: A Fate Decider in the Drug Development

A Phase III clinical study evaluates the safety, efficacy and related parameters of experimental therapy against a standard therapy in a large human population to assure that it is fit for the intended purpose. Mr Chandan, Dr. M P Venkatesh and Dr. T M Pramod Kumar at JSS College of Pharmacy put forward a thesis on how a Phase III clinical trial may compare the effectiveness of a new treatment intervention with the present standard of care, if experimental therapy shows significant activity in any disease condition during the Phase II trial.